3.940USD-0.25%Mkt Cap: 494.34M $P/E: —1d ago
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a su…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap494.34M $
Enterprise Value428.37M $
Revenue (TTM)50.27M $
Gross Profit25.99M $
Net Income (TTM)-83.78M $
Revenue/Share0.4420 USD
Last Price3.940 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees147
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.76
PEG—
EV/EBITDA-7.74
EV/Revenue8.52
P/S9.83
P/B-14.38
EPS (TTM)-0.61
EPS (Forward)-0.45
52W Range
2.93022% of range7.550
52W High7.550 USD
52W Low2.930 USD
Profitability
Gross Margin58.35%
Oper. Margin-29.10%
EBITDA Margin-110.09%
Profit Margin-188.09%
ROE248.90%
ROA-52.23%
Growth
Revenue Growth65.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-52.43M $
CapEx (TTM)562.00K $
FCF Margin-51.10%
FCF Yield-5.20%
Net Debt-67.15M $
Net Debt/EBITDA1.21
Balance Sheet
Debt/Equity-1.26
Current Ratio4.10
Quick Ratio3.70
Book Value/Sh-0.2740 USD
Cash/Share0.8830 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.889 USD
Upside (mean)+125.6%
Target Range6.000 USD – 11.00 USD
$6.000+125.6% to mean$11.00
# Analysts9
Ownership
Shares Out.125.47M
Float114.57M
Insiders3.09%
Institutions58.79%
Short Interest
Short Ratio7.0d
Short % Float13.35%
Short % Out.12.75%
Shares Short16.00M
Short (prev mo.)15.24M
Technical
SMA 504.222 (-6.7%)
SMA 2004.831 (-18.4%)
Beta1.45
S&P 52W Chg20.25%
Avg Vol (30d)1.76M
Avg Vol (10d)1.54M
Technical Indicators
RSI (14)40.0
MACD-0.0606
MACD Signal0.0015
MACD Hist.-0.0622
BB Upper4.951 USD
BB Middle4.325 USD
BB Lower3.698 USD
BB Width28.98%
ATR (14)0.2082 USD
Vol Ratio (20d)1.00x